A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone

Carmine Liberatore; Alfonso Piciocchi; D. Vincelli; Katia Mancuso; Maurizio Musso; Gabriele Buda; Daniele Derudas; Laura Pavan; Angelo Belotti; Angela Rago; L. Paris; Roberto Mina; Concetta Conticello; E. Rossi; Cristina Skert; Fabrizio Accardi; Cristina Clissa; E. Antonioli; Francesca Farina; Anna Furlan; Luca Franceschini; Silvia Mangiacavalli; Claudia Cellini; Sara Aquino; Lorenzo De Paoli; N. Giuliani; Francesco Vassallo; Valeria Sargentini; Stefano Soddu; Sara Bringhen; Massimo Gentile; G Mele; Francesca Patriarca; Sônia Maria Coelho Móre; Francesca Fazio; P. Musto; Francesco Di Raimondo; M. Cavo

doi:10.3324/haematol.2025.300238

March 19, 2026HaematologicaOpen Access

A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone

View Full Paper

Ask AI

Bookmark

Share

Key Points

To evaluate the effectiveness of tandem autologous stem cell transplantation in newly diagnosed multiple myeloma patients treated with specific therapies.
Nationwide survey analysis across Italy
Assessment of treatment protocols including daratumumab, bortezomib, thalidomide, and dexamethasone
Focus on outcomes post-transplantation
Identification of treatment efficacy across various Italian centers
Standardization of post-transplantation care
Potential improvements in patient survival rates

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

A nationwide survey examines treatment outcomes of autologous stem cell transplantation in multiple myeloma, suggesting effective intervention strategies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Liberatore et al. (2026) studied this question.

synapsesocial.com/papers/69be36d46e48c4981c676072 https://doi.org/10.3324/haematol.2025.300238

View Full Paper

Ask AI

Bookmark

Share

A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

A nationwide Italian GIMEMA survey on tandem autologous stem cell transplantation for newly diagnosed multiple myeloma patients treated with daratumumab, bortezomib, thalidomide and dexamethasone

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading